variant (B.1.1.7) was a SARS-CoV-2 variant of concern. It was estimated to be 40–80% more transmissible than the wild-type SARS-CoV-2 (with most estimates...
219 KB (18,220 words) - 12:12, 13 October 2024
The medication is being used in clinical trials to treat patients with SARS-CoV-2 and there are published results in the peer-reviewed scientific literature...
10 KB (793 words) - 08:11, 15 September 2024
cross-reactive immunity to SARS-CoV-2 and provide partial protection against COVID-19. However, co-infection with SARS-CoV-2 and MERS is possible and could...
87 KB (7,259 words) - 23:58, 31 August 2024
Cyber-shot DSC-P3, a Sony Cyber-shot camera SARS-CoV-2 Theta variant, one of the variants of SARS-CoV-2, the virus that causes COVID-19 P3−, the phosphide...
3 KB (402 words) - 04:31, 23 October 2024
Simeprevir (section SARS-CoV-2 research)
of therapy against a Sars-CoV-2 infection.[citation needed] The hepatitis drugs are considered potential inhibitors of SARS-CoV-2 Mpro in the fight against...
26 KB (2,541 words) - 05:04, 4 January 2024
marburg, and SARS-CoV-2. Many BSAs show antiviral activity against other viruses than originally investigated (such as remdesivir and interferon alfa). Efforts...
2 KB (270 words) - 09:20, 24 November 2023
designation α receptors, a type of Adrenergic receptor SARS-CoV-2 Alpha variant, one of the variants of SARS-CoV-2, the virus that causes COVID-19 A class of Immunoglobulin...
10 KB (1,189 words) - 00:43, 30 September 2024
-level-1 laboratory P1 phage, a bacterial virus SARS-CoV-2 Gamma variant, a strain of COVID-19 virus SARS-CoV-2 first detected in Manaus, Brazil in 2020 ATC...
3 KB (526 words) - 18:58, 24 October 2024
and cilgavimab (AZD1061) targeted against the surface spike protein of SARS-CoV-2 used to prevent COVID-19. It is being developed by British-Swedish multinational...
30 KB (1,664 words) - 23:46, 14 October 2024
COVID‑19 vaccine is used to provide protection against infection by the SARS-CoV-2 virus in order to prevent COVID-19 in adults aged 18 years and older....
214 KB (17,080 words) - 15:51, 27 September 2024
SARS-CoV-2 induces an even lower interferon type I (IFN-I) response than SARS-CoV, which itself is a weak IFN-I inducer in human cells. SARS-CoV-2 limits...
62 KB (7,065 words) - 05:17, 28 June 2024
Scientific received emergency use authorization from the FDA for a test for SARS-CoV-2 to help mitigate the COVID-19 pandemic. Thermo Fisher also partnered with...
52 KB (4,337 words) - 04:05, 11 September 2024
centre of attention for driving hyperinflammation in COVID-19, i.e., the SARS-CoV-2 infection triggers hyperinflammation through the JAK/STAT pathway, resulting...
62 KB (6,845 words) - 05:57, 16 October 2024
reached a significant milestone with the FDA-approval of its high-volume Sars-CoV-2 diagnostic test, capable of analysing 1,400-8,800 samples within 24h on...
57 KB (5,180 words) - 21:47, 26 September 2024
(COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of 31 October 2024, according to Indian government figures, India...
337 KB (26,345 words) - 23:53, 10 September 2024
(September 2020). "Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19"...
43 KB (3,613 words) - 02:13, 16 July 2024
has been used in the COVID-19 pandemic. A quarter of all the world's SARS-CoV-2 viral genomes have now been sequenced with nanopore devices. The technology...
39 KB (4,712 words) - 05:31, 30 October 2024
May 2021 the World Health Organization announced that the variants of SARS-CoV-2 of the virus would be named using letters of the Greek alphabet to avoid...
114 KB (8,900 words) - 15:55, 1 November 2024
as an excipient in both the Moderna and Pfizer–BioNTech vaccines for SARS-CoV-2. Both RNA vaccines consist of messenger RNA, or mRNA, encased in a bubble...
38 KB (4,086 words) - 23:17, 23 October 2024
Novel Nasal Spray Sentinox in SARS-CoV-2 Infected Patients". Relief Therapeutics. October 27, 2021. Retrieved December 2, 2021. "Relief Therapeutics -...
14 KB (1,213 words) - 07:40, 8 June 2023
(COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). On 5 March 2020, Minister of Health Zweli Mkhize had confirmed the...
252 KB (12,383 words) - 04:19, 23 August 2024
encephalitis virus, although one study showed that early use of interferon alfa-2b may decrease the severity of complications. In the United States an average...
12 KB (1,290 words) - 20:07, 7 October 2024
prevention of first occurrence of neural tube defects Epoetin alfa, beta and theta; darbepoetin alfa; methoxy polyethylene glycol-epoetin beta; and their quality-assured...
67 KB (4,835 words) - 06:05, 31 October 2024
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). AT-527—a similar drug developed for the treatment of SARS-CoV-2 Tenofovir alafenamide—a nucleotide...
64 KB (5,828 words) - 23:44, 21 October 2024
molecular mechanisms and biomedical applications". Nature Reviews Microbiology. 2 (2): 109–22. doi:10.1038/nrmicro817. ISSN 1740-1526. PMC 7097642. PMID 15043007...
36 KB (1,249 words) - 10:35, 10 July 2024
into 3 areas. These are also known as Traffic conference areas (TC-1 / TC-2 / TC-3) International Civil Aviation Organization (official site) Designators...
3 KB (795 words) - 00:36, 18 July 2024
treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial". The Lancet. Respiratory Medicine. 9 (2): 196–206. doi:10...
32 KB (2,851 words) - 23:22, 16 August 2024
the original on 1 February 2014. Retrieved 26 January 2014. Drotrecogin Alfa (Activated) in Adults with Septic Shock Archived 2015-09-29 at the Wayback...
45 KB (1,903 words) - 16:52, 9 October 2024
European Union at the beginning of the outbreak of more virulent variants of SARS-CoV-2 in early 2021. In May 2023, AstraZeneca's China president said that the...
86 KB (7,963 words) - 18:33, 12 September 2024